Charles Deignan
Director of Finance/CFO en CLEARSIDE BIOMEDICAL, INC. .
Fortuna: 588 533 $ al 31/03/2024
Perfil
Charles A.
Deignan is currently the Chief Financial Officer at Clearside Biomedical, Inc. He previously worked as a Finance Manager at Schering-Plough Corp.
from 1990 to 1994, a Division Controller at AAIPharma, Inc., the President, Chief Financial Officer & Secretary at AtheroGenics, Inc. in 2009, and the Vice President-Finance & Administration at Salutria Pharmaceuticals, Inc. from 2009 to 2011.
Deignan received his undergraduate degree from Boston University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 19/01/2024 | 384 662 ( 0.51% ) | 588 533 $ | 31/03/2024 |
Cargos activos de Charles Deignan
| Empresas | Cargo | Inicio |
|---|---|---|
| CLEARSIDE BIOMEDICAL, INC. | Director of Finance/CFO | 01/01/2012 |
Antiguos cargos conocidos de Charles Deignan.
| Empresas | Cargo | Fin |
|---|---|---|
Salutria Pharmaceuticals, Inc.
 Salutria Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Salutria Pharmaceuticals, Inc. operates drug stores. | Director of Finance/CFO | 01/12/2011 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | President | 14/07/2009 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Director of Finance/CFO | 01/01/1994 |
AAIPharma, Inc.
 AAIPharma, Inc. Miscellaneous Commercial ServicesCommercial Services AAIPharma, Inc. provides product development services to the pharmaceutical, biotechnology and medical device industries. Its services include drug delivery technologies, contract manufacturing, clinical packaging and distribution and bioanalytical services. The company was founded in 1979 and is headquartered in Wilmington, NC. | Corporate Officer/Principal | - |
Formación de Charles Deignan.
| Boston University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CLEARSIDE BIOMEDICAL, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
AAIPharma, Inc.
AAIPharma, Inc. Miscellaneous Commercial ServicesCommercial Services AAIPharma, Inc. provides product development services to the pharmaceutical, biotechnology and medical device industries. Its services include drug delivery technologies, contract manufacturing, clinical packaging and distribution and bioanalytical services. The company was founded in 1979 and is headquartered in Wilmington, NC. | Commercial Services |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
Salutria Pharmaceuticals, Inc.
Salutria Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Salutria Pharmaceuticals, Inc. operates drug stores. | Retail Trade |
- Bolsa de valores
- Insiders
- Charles Deignan
